IMCR Immunocore Holdings plc ADRs

Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$47.56  -1.44 (-2.94%)
As of 02/26/2021 15:55:35 EST     IEX book   CBOE book